Abeta/tau aggregation-IN-4, CAS [[3105860-83-8]] Preis auf Anfrage

Artikelnummer: MCE-HY-180843
Artikelname: Abeta/tau aggregation-IN-4, CAS [[3105860-83-8]] Preis auf Anfrage
Artikelnummer: MCE-HY-180843
Hersteller Artikelnummer: HY-180843
Alternativnummer: MCE-HY-180843-1UNIT
Hersteller: MedchemExpress
Kategorie: Biochemikalien
Abeta/tau aggregation-IN-4 (Compound D21) is an Abeta/tau aggregation inhibitor. Abeta/tau aggregation-IN-4 promotes the degradation of Abeta40/42 (Abeta40, IC50 = 2.151 µM, Abeta42, IC50 = 3.622 µM). Abeta/tau aggregation-IN-4 shows selective AChE inhibition (IC50: 5.56 µM). Abeta/tau aggregation-IN-4 inhibits MAO-A and MAO-B with IC50s of 0.59 µM and 0.09 µM, respectively. Abeta/tau aggregation-IN-4 suppresses intracellular ROS levels. Abeta/tau aggregation-IN-4 can be used in the research of Alzheimers disease[1].
Molekulargewicht: 340.29
CAS Nummer: [3105860-83-8]
Formel: C17H12N2O6
Target-Kategorie: Amyloid-beta,Cholinesterase (ChE),Monoamine Oxidase,Reactive Oxygen Species (ROS),Tau Protein
Anwendungsbeschreibung: MCE Product type: Reference compound